675
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Luteolin protects microglia against rotenone-induced toxicity in a hormetic manner through targeting oxidative stress response, genes associated with Parkinson’s disease and inflammatory pathways

, , &
Pages 96-103 | Received 01 Jun 2018, Accepted 20 Jul 2018, Published online: 12 Sep 2018

References

  • Abe, K., and Matsuki, N., 2000. Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT. Neuroscience Research, 38 (4), 325–329.
  • Casarejos, M.J., 2006. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. Journal of Neurochemistry, 97 (4), 934–946.
  • Crain, J.M., Nikodemova, M., and Watters, J.J., 2013. Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. Journal of Neuroscience Research, 91 (9), 1143–1151.
  • Berger, A.K., et al., 2009. Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release. Human Molecular Genetics, 18 (22), 4317–4328.
  • Blaylock, R.L. and Maroon, J., 2012. Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system. Surgical Neurology International, 3 (1), 19.
  • Block, M.L., Zecca, L., and Hong, J.S., 2007. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews Neuroscience, 8 (1), 57–69.
  • Burton, M.D., et al., 2016. Dietary luteolin reduces pro-inflammatory microglia in the brain of senescent mice. Rejuvenation Research, 19 (4), 286–292.
  • Emmrich, J.V., et al., 2013. Rotenone induces neuronal death by microglial phagocytosis of neurons. The Febs Journal, 280 (20), 5030–5038.
  • Fan, L.W., et al., 2011. Neonatal exposure to lipopolysacchride enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life. Neurobiology Disease, 44 (3), 304–316.
  • Fernández-Moriano, C., González-Burgos, E., and Gómez-Serranillos, M.P., 2015. Mitochondria-targeted protective compounds in parkinson's and Alzheimer's diseases. Oxidative Medicine Cellular Longevity, 2015, 1.
  • Gao, F., et al., 2013. Rotenone directly induces BV2 cell activation via the p38 MAPK pathway. PLoS One, 8 (8), e72046.
  • Gao, F., et al., 2017. Mitophagy in Parkinson's disease: Pathogenic and therapeutic implications. Frontiers in Neurology, 8, 527.
  • Glass, C.K., et al., 2010. Mechanisms underlying inflammation in neurodegeneration. Cell, 140 (6), 918–934.
  • Huang, F., et al., 2011. The inhibitory effect of luteolin on inflammation in LPS-induced microglia. Zhong Yao Cai, 34, 1746–1749.
  • Hwang, S., et al., 2010. Parkin suppresses c-Jun N-terminal kinase-induced cell death via transcriptional regulation in Drosophila. Molecules and Cells, 29 (6), 575–580.
  • Jang, S., Dilger, R.N., and Johnson, R.W., 2010. Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice. The Journal of Nutrition, 140 (10), 1892–1898.
  • Jang, S., Kelley, K.W., and Johnson, R.W., 2008. Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proceedings of. National Academy of. Science. U.S.A, 105 (21), 7534–7539.
  • Jenner, P., 2001. Parkinson's disease, pesticides and mitochondrial dysfunction. Trends in Neurosciences, 24 (5), 245–246.
  • Johnson, M.E. and Bobrovskaya, L., 2015. An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. Neurotoxicology, 46, 101–116.
  • Kaur, C., Rathnasamy, G., and Ling, E.A., 2017. Biology of Microglia in the Developing Brain. Journal of Neuropathology and Experimental Neurology, 76 (9), 736–753.
  • Kettenmann, H., et al., 2011. Physiology of microglia. Physiological Reviews, 91 (2), 461–553.
  • Liang, Y., et al., 2017. Rifampicin inhibits rotenone-induced microglial inflammation via enhancement of autophagy. Neurotoxicology, 63, 137–145.
  • Liu, H.F., et al., 2017. Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease. Scientific Reports, 7, 40887
  • Livak, K.J. and Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.), 25 (4), 402–408.
  • Maturana, M.G., et al., 2015. Unveiling the role of the pesticides paraquat and rotenone on α-synuclein fibrillation in vitro. Neurotoxicology, 46, 35–43.
  • Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65 (1-2), 55–63.
  • Neher, J.J., et al., 2011. Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death. Journal of Immunology, 186 (8), 4973–4983.,
  • Oka, S.I., et al., 2017. Thioredoxin-1 maintains mTOR function during oxidative stress in cardiomyocytes. Journal of Biological Chemistry, 292 (46), 18988–19000.,
  • Park, H.J., et al., 2006. Epigallocatechin gallate reduces hypoxia-induced apoptosis in human hepatoma cells. Life Sciences, 78 (24), 2826–2832.,
  • Pfaffl, M.W., Horgan, G.W., and Dempfle, L., 2002. Relative expression software tool (REST) for group wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Research, 30 (9), 36e.
  • Przedborski, S., and Ischiropoulos, H., 2005. Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease. Antioxid. Redox Signal, 7 (5-6), 685–693.
  • Rangarajan, P., Karthikeyan, A., and Dheen, S.T., 2016. Role of dietary phenols in mitigating microglia-mediated neuroinflammation. Neuromolecular Medicine, 18 (3), 453–464.
  • Schapira, A. and Jenner, P., 2011. Etiology and pathogenesis of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society, 26 (6), 1049–1055.
  • Sherer, T.B., et al., 2002. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. Journal of Neuroscience, 22 (16), 7006–7015.
  • Sonia, Angeline, M., et al., 2012. Rotenone-induced parkinsonism elicits behavioral impairments and differential expression of parkin, heat shock proteins and caspases in the rat. Neuroscience, 220, 291–301.
  • Spencer, J.P., et al., 2012. Neuroinflammation: modulation by flavonoids and mechanisms of action. Molecular Aspects of Medicine, 33 (1), 83–97.
  • Spivey, A., 2011. Rotenone and paraquat linked to Parkinson's disease: human exposure study supports years of animal studies. Environmental Health Perspectives, 119 (6), A259
  • Tamilselvam, K., et al., 2013. Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson's disease. Oxidative Medicine and Cellular Longevity, 2013, 1.
  • Tsilioni, I., et al., 2015. Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Translational Psychiatry, 5, e647.
  • Wang, Y., et al., 2017. Ultrafine carbon particles promote rotenone-induced dopamine neuronal loss through activating microglial NADPH oxidase. Toxicology and Applied Pharmacology, 322, 51–59.
  • Xicoy, H., Wieringa, B., and Martens, G.J., 2017. The SH-SY5Y cell line in Parkinson's disease research: a systematic review. Molecular Neurodegeneration, 12 (1), 10.
  • Zhang, J.X., et al., 2017. Luteolin inhibits fibrillary β-amyloid 1-40-induced inflammation in a human blood-brain barrier model by suppressing the p38 MAPK-mediated NF-κB signaling pathways. Molecules, 22 (3), 334.
  • Zhou, Q., et al., 2015. Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis. Toxicological Sciences, 143 (1), 81–96.
  • Zhu, L.H., et al., 2011b. Luteolin inhibits microglial inflammation and improves neuron survival against inflammation. International Journal of Neuroscience, 121 (6), 329–336.
  • Zhu, L.H., et al., 2011b. Luteolin reduces primary hippocampal neurons death induced by neuroinflammation. Neurological Research, 33 (9), 927–934.
  • Zhu, L., et al., 2014. Luteolin inhibits SH-SY5Y cell apoptosis through suppression of the nuclear transcription factor-κB, mitogen-activated protein kinase and protein kinase B pathways in lipopolysaccharide-stimulated co-cultured BV2 cells. Experimental and Therapeutic Medicine, 7 (5), 1065–1070.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.